Vyne Therapeutics Inc.
VYNE
Revenue
198.00k
▲100.00k▲102.04%
3 Months ChangeAssets
86.65M
▼-5.03M▼-5.48%
3 Months ChangeLiabilities
11.78M
▲3.47M▲41.81%
3 Months ChangeFree Cash Flow
-12.55M
▲39.70M▲75.98%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001104659-24-099121
2024-08-14
Form 10-Q
ID: 0001628280-24-037176
2024-08-14
Form 8-K
ID: 0001628280-24-037051
2024-05-09
Form 10-Q
ID: 0001628280-24-022183
2024-05-09
Form 8-K
ID: 0001628280-24-021971
2024-02-29
Form 8-K
ID: 0001104659-24-029097
2024-01-03
Form 8-K
ID: 0001104659-24-000584
2023-12-13
Form 8-K
ID: 0001104659-23-125694
2023-11-13
Form 10-Q
ID: 0001628280-23-038414
2023-11-13
Form 8-K
ID: 0001104659-23-116712